The biggest difference between ocrelizumab and the recently approved ofatumumab is that ofatumumab can be taken at home for relapsing forms of multiple sclerosis (MS), explained Patricia K. Coyle, MD.

Multiple sclerosis (MS) is a chronic disease of the central nervous system that causes disruptions in the flow of information within the brain and between the brain and body, eventually causing ...

Early intervention and effective therapies are transforming multiple sclerosis management, enhancing patient outcomes, and delaying disability progression.

At Race to Erase MS 2023, scientists gathered to discuss the latest research, from ‘designer estrogen’ aimed at preventing brain atrophy in women to next-gen blood tests powered by AI. In 1993, ...

Multiple sclerosis (MS) symptoms can affect different parts of your body and brain. No two people have the same problems, so your doctors will develop a treatment plan just for you, whether the ...

Doctors in Cambridge believe they are “on the brink of a new class of treatments” for multiple sclerosis (MS) after a trial in patients suggested nerve damage may be repaired. The treatment involves ...

Improvements in safety, efficacy, and specificity have raised questions around the benefits and risks of switching treatments for this type of MS, especially from fingolimod to siponimod. There are ...

In a cohort of Black and Hispanic individuals with relapsing MS, baseline comorbidities had no significant effect on the ...